Genomic amplification of CDK4 in dedifferentiated liposarcomas as a predictive biomarker for microtubule disrupting agents.

Bryce Demoret,Andrew H. Rogers,Nathan D. Seligson,Esko A. Kautto,John L. Hays,James L. Chen

Genomic amplification of CDK4 in dedifferentiated liposarcomas as a predictive biomarker for microtubule disrupting agents.

2018

Bryce Demoret
Andrew H. Rogers
Nathan D. Seligson
Esko A. Kautto
John L. Hays
James L. Chen

11581Background: Dedifferentiated liposarcoma (DDLPS) represents a common but morbid subtype of sarcoma. Microtubule disrupting agents (MDA), including eribulin and taxanes, disrupt the cell cycle ...

Keywords:

Cancer research
Pathology
Microtubule
Biomarker (medicine)
Medicine
Eribulin
predictive biomarker
Sarcoma
Dedifferentiated liposarcoma
Cell cycle

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations